Amphastar Pharma (AMPH) Tops Q2 EPS by 4c

Amphastar Pharma (NASDAQ: AMPH) reported Q2 Adj. EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.2 million versus the consensus estimate of $63.3 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Northern Technologies (NTIC) Misses Q3 EPS by 12c
• Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook